Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2

Genes, Chromosomes & Cancer
Kathleen ClaesLudwine Messiaen

Abstract

About 4% of all BRCA1 and BRCA2 alterations reported to the Breast Information Core database are splice site variants. Only a limited number of them have been studied at the RNA level. By BRCA1 and BRCA2 mutation analysis of breast/ovarian cancer families, we identified two novel and eight previously reported potential splice site mutations, never characterized at the cDNA level before. RT-PCR was performed to determine whether these variants disrupted correct splicing. To ensure efficient detection of transcripts containing premature termination codons, a nonsense-mediated mRNA decay inhibitor was added to the lymphoblastoid cell lines of the patients before RNA extraction. We found that BRCA1 IVS3+3A>C, 4304G>A (in the last codon of exon 12), and IVS19+2delT and BRCA2 IVS6+1G>A, IVS23-2A>G, and IVS24+1G>A lead to aberrant transcripts in lymphocytes. Therefore, they were considered to be true pathogenic mutations, predisposing carriers to cancers of the hereditary breast/ovarian cancer syndrome. BRCA2 IVS24-16T>C is a frequent polymorphism in linkage disequilibrium, with a polymorphic stop codon in exon 27, K3326X. BRCA1 IVS2-14C>T and BRCA2 IVS9-5insT and IVS25+9A>C represent rare variants, not disrupting normal splicing in b...Continue Reading

References

Dec 1, 1990·Molecular and Cellular Biology·M Talerico, S M Berget
Jan 1, 1986·Annual Review of Genetics·M R Green
Jan 1, 1996·Annual Review of Biochemistry·A Krämer
Nov 1, 1996·Nature Genetics·S MazoyerG M Lenoir
Feb 3, 1999·Annual Review of Genetics·N Rahman, M R Stratton
Oct 20, 2000·European Journal of Human Genetics : EJHG·L SarantausH Nevanlinna
Mar 21, 2001·Human Molecular Genetics·P L Welcsh, M C King
Jan 22, 2002·International Journal of Cancer. Journal International Du Cancer·A Meindl, UNKNOWN German Consortium for Hereditary Breast and Ovarian Cancer

❮ Previous
Next ❯

Citations

Sep 28, 2007·Breast Cancer Research and Treatment·Christopher A PettigrewMelissa A Brown
Mar 10, 2009·Breast Cancer Research and Treatment·Thomas V O HansenFinn C Nielsen
Jun 15, 2011·Breast Cancer Research and Treatment·Cristina BaliaMaria Adelaide Caligo
Jul 8, 2011·Breast Cancer Research and Treatment·Mireia MenéndezConxi Lázaro
May 3, 2013·Journal of Human Genetics·Jelena DobričićMirjana Branković-Magić
Jun 24, 2006·Genetic Testing·Mads ThomassenAnne-Marie Gerdes
Feb 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P RadiceS Tommasi
Sep 6, 2005·Nucleic Acids Research·Jana KrálovicováIgor Vorechovský
Mar 31, 2009·BMC Molecular Biology·Aaron M GruverDouglas L Pittman
Jan 1, 2006·Hereditary Cancer in Clinical Practice·Lenka ForetovaPetr Pohlreich
Dec 3, 2008·Disease Models & Mechanisms·James D Fackenthal, Lucy A Godley
Nov 21, 2015·Journal of the National Cancer Institute·Huong D MeeksDavid E Goldgar
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Taiping ChenJulia H Carter
Jul 21, 2004·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Shirley V HodgsonMelita Irving
Jan 26, 2013·Human Mutation·Eliseos J MucakiPeter K Rogan
Apr 28, 2011·Human Mutation·Eliseos J MucakiPeter K Rogan
Jul 6, 2004·Clinical Biochemistry·Brigitta M N Brinkman
Oct 3, 2006·Cancer Genetics and Cytogenetics·Fabrizia BonattiMaria Adelaide Caligo
Aug 1, 2006·Cancer Genetics and Cytogenetics·Philippe MailletUNKNOWN SIAK Network for Cancer Predisposition Testing and Counseling
Nov 22, 2011·Journal of Molecular Biology·Monica PassoniEmanuele Buratti
May 18, 2016·Breast Cancer Research : BCR·Annelot BaertAnne Vral
Mar 29, 2014·European Journal of Human Genetics : EJHG·Ane Y SteffensenThomas vO Hansen
Jan 10, 2019·International Journal of Cancer. Journal International Du Cancer·Rita D BrandãoMarinus J Blok
Sep 16, 2011·Familial Cancer·Fatemeh KeshavarziSirous Zeinali
Apr 10, 2016·Journal of Medical Genetics·James D FackenthalMiguel de la Hoya
May 14, 2020·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Romy L S MesmanMaaike P G Vreeswijk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.